OSTEONECROSIS TREATMENT MARKET ANALYSIS

Regional Analysis

Osteonecrosis Treatment Market – Regional Analysis

On the basis of region, the global osteonecrosis treatment market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold a dominant position in the global osteonecrosis treatment market over the forecast period due to increasing prevalence pool of osteonecrosis, prior Food and Drug Administration (FDA) approval for the new treatments in this region. For instance, according to NCBI 2015, it is estimated that around 20,000 to 30,000 new patients are diagnosed with osteonecrosis annually in the U.S.  Asia Pacific is also expected to witness faster growth in the global osteonecrosis treatment market over the forecast period, owing to increase in development activities by various key players in this region. For instance, Bone Therapeutics and Asahi Kasei Corporation signed a license agreement in 2017 for the development and commercialization of PREOB in Japan.